WuXi Biologics (Cayman) I... (WXIBF)

PNK: WXIBF · Real-Time Price · USD

3.00

0.00 (0.00%)

At close: Apr 29, 2025, 3:47 PM

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	17.03B	15.27B	10.29B	5.61B	3.98B	2.53B	1.62B	989.03M
Cost of Revenue	10.21B	8.54B	5.46B	3.08B	2.32B	1.52B	958.27M	599.92M
Gross Profit	6.83B	6.72B	4.83B	2.53B	1.66B	1.02B	660.56M	389.11M
Operating Income	3.95B	6.16B	3.86B	1.76B	1.11B	876.43M	348.64M	201.54M
Interest Income	219.18M	107.47M	58.03M	80.86M	63.86M	78.39M	8.75M	413K
Pretax Income	4.17B	5.36B	3.99B	1.97B	1.13B	737.72M	303.69M	175.85M
Net Income	3.4B	4.42B	3.39B	1.69B	1.01B	630.59M	252.63M	141.1M
Selling & General & Admin	2.09B	1.43B	1B	605.85M	444.37M	270.15M	161.64M	109.04M
Research & Development	785.82M	682.82M	501.58M	303.73M	259.65M	169.29M	74.48M	53.28M
Other Expenses	n/a	-189.66M	-137.93M	-138.15M	-102.25M	-115.82M	-12.2M	-438K
Operating Expenses	2.88B	1.93B	1.36B	771.43M	601.77M	323.62M	223.92M	161.88M
Interest Expense	158.49M	64.38M	39.19M	42.73M	19.61M	138.59M	35.69M	24.16M
Selling & Marketing Expenses	294.01M	162.91M	124.65M	94.42M	77.08M	42.43M	27.62M	15.33M
Cost & Expenses	13.08B	10.47B	6.83B	3.85B	2.93B	1.84B	1.18B	761.8M
Income Tax Expense	603.18M	807.87M	484.54M	273.07M	116.3M	107.26M	51.06M	34.75M
Shares Outstanding (Basic)	4.16B	4.17B	4.4B	4.21B	4B	3.94B	3.22B	3.4B
Shares Outstanding (Diluted)	4.35B	4.38B	4.42B	4.21B	4B	3.94B	3.48B	3.4B
EPS (Basic)	0.81	1.06	0.81	0.43	0.27	0.16	0.08	0.04
EPS (Diluted)	0.77	1.01	0.77	0.40	0.25	0.16	0.07	0.04
EBITDA	5.5B	6.22B	4.51B	2.31B	1.37B	881.49M	471.39M	319.08M
EBIT	4.33B	5.42B	4.03B	2.01B	1.15B	737.72M	339.38M	200M
Depreciation & Amortization	1.17B	800.67M	481.78M	303.01M	221.37M	143.77M	122.75M	93.19M